Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.26 | 34.99 |
| PEG Ratio (TTM) | 0.15 | 2.49 |
| P/S Ratio (TTM) | 8.79 | 3.95 |
| P/B Ratio (TTM) | 0.04 | 7.17 |
| P/FCF Ratio (TTM) | N/A | 22.55 |
| Price to 5YR AVG Earnings Ratio | -0.01 | 35.61 |
| Price to 5YR AVG FCF Ratio | -0.74 | 27.38 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.19% | 6.27% |
| ROE (TTM) | 0.23% | 21.08% |
| Net Profit Margin (TTM) | 2.71% | 10.00% |
| ROIC 5YR AVG | -50.65% | 19.79% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 109.64% | -39.58% | -34.80% |
| Revenue | -11.93% | -43.79% | -36.83% |
| Net Income | 118.36% | -46.89% | -43.48% |
| Cash Flow | N/A | -112.69% | -42.36% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.33 | 1.71 |
| Quick Ratio (TTM) | 6.33 | 1.71 |
| D/E Ratio (TTM) | N/A | 1.08 |
| Interest Coverage (TTM) | N/A | 31.33 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 0.45 | 5.37 |
| LTL to 5YR AVG FCF | -0.03 | 3.64 |
| Shares Outstanding Growth 5YR AVG | 4.30% | 2.35% |